Covid-19 Vaccine Booster Dose and The Indian Scenario: When We Will Have a Fully Immunized Population?

Authors

  • Amitesh Datta Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India
  • Sahjid Mukhida Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India
  • Sundip Mukherjee Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India
  • Akash Korat Pacific Medical College & Hospital, Girwa, Udaipur, Rajasthan, India
  • Sameena Khan Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India
  • Preethy Edavaloth Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India

DOI:

https://doi.org/10.55489/njcm.140920233171

Keywords:

COVID-19, Booster dose, Indian scenario

Abstract

NA

References

Fisher KA, Nguyen N, Fouayzi H, Crawford S, Singh S, Dong M, et al. From COVID-19 Vaccine Hesitancy to Vaccine Ac-ceptance: Results of a Longitudinal Survey. Public Health Re-ports. 2023;0(0). Doi: https://doi.org/10.1177/00333549231176006 PMid:37243439 PMCid:PMC10235915

Masthi Nr R, Brahmajosyula A, Khamar A, Acharya N, Bili-chod LP, Kondath D. Coverage of Coronavirus Disease-2019 (COVID-19) Booster Dose (Precautionary) in the Adult Popu-lation: An Online Survey. Cureus. 2022 Jul 16;14(7): e 26912. Doi: https://doi.org/10.7759/cureus.26912 PMid:35983381 PMCid:PMC9376214

Precaution Dose to be now available to 18+ population group from 10th April, 2022, at Private Vaccination Centres Posted On: 08 APR 2022 3:01PM by Ministry of Health and Family Welfare https://pib.gov.in/PressReleasePage.aspx?PRID= 1814804 Last accessed on 1st March 2023.

Bhaumik S, MUKHIDA S, Das N, Khan S, Patil R, Kannuri S. Can Vaccines Alone Bring an End to This Pandemic? Natl J Com-munity Med. 2023 Mar. 31 [cited 2023Jun.1];14(03):208-9. Doi: https://doi.org/10.55489/njcm.140320232647

Mukhida S, Kannuri S, Das NK, Khan S, Patil R. Is a vaccine one of the factors that will contribute to the end of the Pandemic? Iranian Journal of Medical Microbiology. 2023.06.08 (ahead of Print).

Vaccine State Data published on Ministry of the Health and Family Welfare data checked on 1st March 2023. Available on https://www.mohfw.gov.in/ last accessed on 1st March 2023.

Gupta A, Bhoyar R, Mirza S, Jolly B, Senthivel V, Shamnath A, et al. SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker. J Infect. 2022; 84(3):418-467. Doi: https://doi.org/10.1016/j.jinf.2021.10.008 PMid:34678389 PMCid:PMC8523545

Mukhida S, Vyawahare C, Verma P, Khan S, Das N. Are the Cur-rent COVID-19 Cases Post-Phase of 3rd Wave or Pre-phase of 4th Wave in India? Iran J Med Microbiol 2023; 17 (2):270-272. Doi: https://doi.org/10.30699/ijmm.17.2.270

Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology. https://pib.gov.in/ Press ReleasePage.aspx?PRID=1933586.

Downloads

Published

2023-09-01

How to Cite

1.
Datta A, Mukhida S, Mukherjee S, Korat A, Khan S, Edavaloth P. Covid-19 Vaccine Booster Dose and The Indian Scenario: When We Will Have a Fully Immunized Population?. Natl J Community Med [Internet]. 2023 Sep. 1 [cited 2024 Nov. 25];14(09):624-5. Available from: https://njcmindia.com/index.php/file/article/view/3171

Issue

Section

Letter to Editor